Floatz logo

1,125 assets in Non-Small Cell Lung Carcinoma

Therapeutic assets addressing Non-Small Cell Lung Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
ly4175408
Non-Small Cell Lung Carcinoma
Eli Lilly and CompanyP1C (37)
Mem-288 Intratumoral
Non-Small Cell Lung Carcinoma
Memgen, Inc.P1C (37)
MGC026
Non-Small Cell Lung Carcinoma
MacroGenicsP1C (37)
Mrtx0902
Non-Small Cell Lung Carcinoma
Mirati Therapeutics Inc.P1C (37)
Mrtx1719
Non-Small Cell Lung Carcinoma
Bristol-Myers SquibbP1C (37)
mt-8421
Non-Small Cell Lung Carcinoma
Molecular Templates, Inc.P1C (37)
Mytx-011
Non-Small Cell Lung Carcinoma
Mythic TherapeuticsP1C (37)
Nab-Sirolimus
Non-Small Cell Lung Carcinoma
Mirati Therapeutics Inc.P1C (37)
ngm438
Non-Small Cell Lung Carcinoma
NGM Biopharmaceuticals, IncP1C (37)
Nrm-823
Non-Small Cell Lung Carcinoma
Normunity AccelCo, Inc.P1C (37)
Nst-628
Non-Small Cell Lung Carcinoma
Nested Therapeutics, IncP1C (37)
okn4395
Non-Small Cell Lung Carcinoma
EpkinP1C (37)
Ono-7428
Non-Small Cell Lung Carcinoma
Ono Pharmaceutical Co., Ltd.P1C (37)
Oric-114
Non-Small Cell Lung Carcinoma
ORIC PharmaceuticalsP1C (37)
Ovm-200
Non-Small Cell Lung Carcinoma
Oxford Vacmedix UK Ltd.P1C (37)
Parimparib
Non-Small Cell Lung Carcinoma
Affiliated Hospital of Jiangnan UniversityP1C (37)
Pebezertinib
Non-Small Cell Lung Carcinoma
Blueprint Medicines CorporationP1C (37)
pf-07265028
Non-Small Cell Lung Carcinoma
PfizerP1C (37)
pf-07921585
Non-Small Cell Lung Carcinoma
PfizerP1C (37)
pf-07934040
Non-Small Cell Lung Carcinoma
PfizerP1C (37)
pf-07985045
Non-Small Cell Lung Carcinoma
PfizerP1C (37)
pf-08046050
Non-Small Cell Lung Carcinoma
Seagen, a wholly owned subsidiary of PfizerP1C (37)
pf-08046052
Non-Small Cell Lung Carcinoma
Seagen, a wholly owned subsidiary of PfizerP1C (37)
pf-08052666
Non-Small Cell Lung Carcinoma
Seagen, a wholly owned subsidiary of PfizerP1C (37)
P-Muc1C-Allo1 Car-T Cells
Non-Small Cell Lung Carcinoma
Poseida Therapeutics, Inc.P1C (37)
Prth-101
Non-Small Cell Lung Carcinoma
Incendia TherapeuticsP1C (37)
qeq278
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1C (37)
Rimiducid
Non-Small Cell Lung Carcinoma
Poseida Therapeutics, Inc.P1C (37)
Rndo-564
Non-Small Cell Lung Carcinoma
Rondo TherapeuticsP1C (37)
Sgn-Alpv
Non-Small Cell Lung Carcinoma
Seagen Inc.P1C (37)
Slv-154
Non-Small Cell Lung Carcinoma
Solve TherapeuticsP1C (37)
Tgrx-1942
Non-Small Cell Lung Carcinoma
Shenzhen TargetRx Co., Ltd.P1C (37)
Tolododekin Alfa
Non-Small Cell Lung Carcinoma
Ankyra Therapeutics, IncP1C (37)
Wm-A1-3389
Non-Small Cell Lung Carcinoma
Wellmarker BioP1C (37)
Xzb-0004
Non-Small Cell Lung Carcinoma
Xuanzhu Biopharmaceutical Co., Ltd.P1C (37)
zm008
Non-Small Cell Lung Carcinoma
Zumutor Biologics Inc.P1C (37)
177lu-dfc413
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1C (36)
[177lu]lu-nns309
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1C (36)
[18F]DK222
Non-Small Cell Lung Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP1C (36)
[225ac]-fpi-2068
Non-Small Cell Lung Carcinoma
AstraZenecaP1C (36)
[68Ga]Ga-NNS309
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1C (36)
68Ga-NNS309
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1C (36)
Abbv-400
Non-Small Cell Lung Carcinoma
AbbVieP1C (36)
Absk112
Non-Small Cell Lung Carcinoma
Abbisko Therapeutics Co, LtdP1C (36)
Amg 160
Non-Small Cell Lung Carcinoma
AmgenP1C (36)
Anti-Clever-1 Monoclonal Antibody Fp-1305
Non-Small Cell Lung Carcinoma
The University of Texas Health Science Center at San AntonioP1C (36)
asp1893
Non-Small Cell Lung Carcinoma
Astellas Pharma Global Development, Inc.P1C (36)
Autologous, Engineered T Cells Targeting Tp53 R175H
Non-Small Cell Lung Carcinoma
AstraZenecaP1C (36)
Autologous Genetically Modified Mage-A4ᶜ¹º³²T Cells
Non-Small Cell Lung Carcinoma
USWM CT, LLCP1C (36)
AZD0240
Non-Small Cell Lung Carcinoma
AstraZenecaP1C (36)
Showing 901 to 950 of 1,125 assets
PreviousPage 19 of 23Next